In-vitro performance of two valved holding chambers (VHCs)/Spacers for paediatric use tested with facemasks attached is unaffected by routine use and cleaning
L. Jacques, J. Mitchell, M. Nagel, H. Mackay, K. Wiersema, A. Cripps, S. Pischel, W. Lincourt (London, ON, Canada; Ware/Herts, United Kingdom; RTP, NC, United States Of America)
Source: Annual Congress 2008 - Wheezing in preschool children
Session: Wheezing in preschool children
Session type: Thematic Poster Session
Number: 3956
Disease area: Paediatric lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Jacques, J. Mitchell, M. Nagel, H. Mackay, K. Wiersema, A. Cripps, S. Pischel, W. Lincourt (London, ON, Canada; Ware/Herts, United Kingdom; RTP, NC, United States Of America). In-vitro performance of two valved holding chambers (VHCs)/Spacers for paediatric use tested with facemasks attached is unaffected by routine use and cleaning. Eur Respir J 2008; 32: Suppl. 52, 3956
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Breath-by-breath delivered dose comparison from three anti-static valved holding chambers with facemasks under simulated pediatric breathing conditions Source: Annual Congress 2011 - Treating childhood asthma Year: 2011
Not all antistatic valved holding chambers have equivalent performance: An example why each valved holding chamber (VHC)-inhaler combination should be considered unique Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
In vitro testing of inhalation devices with face masksSource: Eur Respir J 2001; 18: Suppl. 33, 494s Year: 2001
Performance of a valved holding chamber with tracheostomy adapter: comparison with conventional valved holding chamber Source: Eur Respir J 2001; 18: Suppl. 33, 134s Year: 2001
Patient centered development of a new valved holding chamber (VHC) designed specifically for on-the-go use Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020
Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC) Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019
New anti-static youth valved holding chamber (VHC) can be used out-of-package and deliver β2 -agonist medication effectively Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009
Delivery of medication via a novel non-electrostatic valved holding chamber (VHC) for infant use depends on the number of inhalations Source: Eur Respir J 2006; 28: Suppl. 50, 713s Year: 2006
In vitro delivery of an HFA-based corticosteroid by pediatric and adult valved holding chambers (VHC): effect of inhalation flow rateSource: Eur Respir J 2002; 20: Suppl. 38, 500s Year: 2002
Valved holding chambers vary considerably in drug delivery efficacy Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment Year: 2018
Priming of a non-conducting valved holding chamber (VHC) is formulation dependent and may result in inconsistent medication delivery Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007
Valved holding chamber drug delivery is dependent on breathing pattern and device design Source: ERJ Open Res, 5 (1) 00158-2018; 10.1183/23120541.00158-2018 Year: 2019
Medication delivery via infant and child valved holding chambers (VHCs) with facemask is aided with inhalation flow indicator Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008
In vitro performance of a new non-electrostatic, transparent valved holding chamber (VHC) for the poorly coordinated patientSource: Eur Respir J 2004; 24: Suppl. 48, 380s Year: 2004
A small volume valved holding chamber (VHC) manufactured from charge dissipative materials has comparable in vitro performance with a large volume non-conducting plastic spacer for both bronchodilator and anti-inflammatory formulations Source: Eur Respir J 2005; 26: Suppl. 49, 340s Year: 2005
Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation Source: Eur Respir J 2002; 20: Suppl. 38, 500s Year: 2002
Impact of inspiratory delay and valved holding chamber (VHC) material on drug delivery Source: Eur Respir J 2001; 18: Suppl. 33, 494s Year: 2001
Evaluation of the technique of use of inhaler devices by patients at home through a video mobile application: A pilot study Source: International Congress 2019 – Clinical implications of asthma management Year: 2019
Is pretreatment of a valved holding chamber (VHC) by priming with medication as effective as washing in ionic detergent? Source: Eur Respir J 2004; 24: Suppl. 48, 308s Year: 2004
A visual indicator for inhalation from a valved holding chamber (VHC) is an aid in delivery of inhaled medication to infants and small children via facemask Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009